Legal Opinion
Amgen, Inc., and Ortho Biotech, Inc., Omj Pharmaceutical, Inc. And Ortho Pharmaceutical Corp. v. Genetics Institute, Inc.
Court of Appeals for the Federal Circuit
Decided January 3, 1997No. 95-1247PublishedCited by 20 opinions
1Opinion of the Court
PAULINE NEWMAN, Circuit Judge.
At issue in this declaratory action is United States Patent No. 5,322,837 (the ’837 patent) entitled “Homogeneous Erythropoietin Compositions and Methods of Using Same.” The patentee is Genetics Institute, Inc.; the accused infringers are Amgen, Inc. and its distributors or licensees Ortho Biotech, Inc., OMJ Pharmaceuticals, Inc. and Ortho Pharmaceutical Corp. (collectively herein Amgen).
The ’837 patent is a continuation of United States Patent No. 4,677,195 (the ’195 patent), having the same specification. In a previous suit involving the same parties in…
2Cases cited12 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Parklane Hosiery Co. v. ShoreSupreme Court of the United States · 1979
- Montana v. United StatesSupreme Court of the United States · 1979
- Brown v. FelsenSupreme Court of the United States · 1979
7 more not listed; retrieve them via the Exa API.
3Cited by20 opinions
- Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc.Court of Appeals for the Federal Circuit · 2009
- City of Salem v. Massachusetts Commission Against DiscriminationMassachusetts Appeals Court · 1998
- International Nutrition Company v. Horphag Research, Ltd.Court of Appeals for the Federal Circuit · 2000
- Amgen, Inc. v. Hoechst Marion Roussel, Inc.District Court, D. Massachusetts · 2001
- Mycogen Plant Science, Inc., and Agrigenetics, Inc. v. Monsanto Company, DefendantCourt of Appeals for the Federal Circuit · 2001
15 more not listed; retrieve them via the Exa API.